Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.46 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.46 |
| ▸ | HRH1 | P35367 | 2/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.46 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | HRH2 | P25021 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.46 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9226011 | 0.90 | TSHR (0.43) | MAPTLMNAKMT2AMEN1ALDH1A1 | |
| SCHEMBL11387106 | 0.84 | MEN1 (0.50) | LMNASLC6A4KMT2AMEN1L3MBTL1 | |
| SCHEMBL9231158 | 0.84 | LMNA (0.50) | MAPTLMNASLC6A4ALDH1A1L3MBTL1 | |
| SCHEMBL4064320 | 0.83 | PTGER1 (0.44) | MAPTLMNACHRM2CHRM5CHRM1 | |
| SCHEMBL12121777 | 0.83 | PTGER1 (0.44) | MAPTLMNACHRM2CHRM5CHRM1 | |
| SCHEMBL579976 | 0.83 | CHRM2 (0.46) | MAPTLMNACHRM2CHRM1KMT2A | |
| SCHEMBL580492 | 0.83 | CHRM2 (0.46) | MAPTLMNACHRM2CHRM1KMT2A | |
| SCHEMBL579637 | 0.83 | CHRM2 (0.46) | MAPTLMNACHRM2CHRM1KMT2A | |
| SCHEMBL579703 | 0.82 | CYP1A2 (0.43) | MAPTKMT2AMEN1TNFTSHR | |
| SCHEMBL580496 | 0.82 | CYP1A2 (0.43) | MAPTKMT2AMEN1TNFTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010092500-A2 | A PROCESS FOR THE PREPARATION OF TOLTERODINE TARTRATE | ALEMBIC LIMITED (IN) | 2010-08-19 | — | — | WO | claimed |
| WO-2010046801-A2 | A PROCESS FOR THE PREPARATION OF TOLTERODINE TARTRATE | ALEMBIC LIMITED (IN) | 2010-04-29 | — | — | WO | claimed |
| EP-1419135-A4 | PROCESS FOR THE PREPARATION OF TOLTERODINE | RANBAXY LAB LTD (IN) | 2006-01-11 | — | — | EP | claimed |
| US-20040249211-A1 | PROCESS FOR THE PREPARATION OF TOLTERODINE | RANBAXY LABORATORIES LIMITED (IN) | 2004-12-09 | — | — | US | claimed |
| US-6822119-B1 | REACTING 3,4-DIHYDRO-6-METHYL-4-PHENYL-2H-BENZOPYRAN-2-ONE WITH DIMETHYL SULFATE USING PHASE TRANSFER CATALYST; DESTERIFICATION, REDUCTION, AMINATION, SULFONATION, DEPROTECTING, DECYCLIZATION, AND SALT FORMATION | RANBAXY LABORATORIES LIMITED (IN) | 2004-11-23 | — | — | US | claimed |
| EP-1419135-A1 | PROCESS FOR THE PREPARATION OF TOLTERODINE | RANBAXY LABORATORIES, LTD. (IN) | 2004-05-19 | — | — | EP | claimed |
| WO-2003014060-A1 | PROCESS FOR THE PREPARATION OF TOLTERODINE | RANBAXY LABORATORIES LIMITED (IN) | 2003-02-20 | — | — | WO | claimed |
| EP-1927585-B1 | METHOD OF OBTAINING 3,3-DIPHENYLPROPYLAMINES | INTERQUIM SA (ES) | 2016-07-27 | — | — | EP | disclosed |
| US-9085509-B2 | Process for preparing fesoterodine | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2015-07-21 | — | — | US | disclosed |
| US-9085509-B2 | Process for preparing fesoterodine | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2015-07-21 | — | — | US | disclosed |
| EP-2686288-B1 | A PROCESS FOR PREPARING FESOTERODINE | ALEMBIC PHARMACEUTICALS LTD (IN) | 2015-03-25 | — | — | EP | disclosed |
| US-20140039216-A1 | PROCESS FOR PREPARING FESOTERODINE | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2014-02-06 | — | — | US | disclosed |
| US-20140039216-A1 | PROCESS FOR PREPARING FESOTERODINE | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2014-02-06 | — | — | US | disclosed |
| EP-1698615-A1 | METHOD OF OBTAINING TOLTERODINE | Ragactives, S.L. (ES) | 2006-09-06 | — | — | EP | disclosed |
| US-20060094904-A1 | Reacting methyl 3-(2-benzyloxy-5-methyl phenyl)-3-phenylpropionate with a reducing agent to form 3-(2-benzyloxy-5-methylphenyl)-3-phenylpropanol | DR. REDDY'S LABORATORIES LIMITED (IN) | 2006-05-04 | — | — | US | disclosed |
| EP-1419135-A4 | PROCESS FOR THE PREPARATION OF TOLTERODINE | RANBAXY LAB LTD (IN) | 2006-01-11 | — | — | EP | disclosed |
| US-20040249211-A1 | PROCESS FOR THE PREPARATION OF TOLTERODINE | RANBAXY LABORATORIES LIMITED (IN) | 2004-12-09 | — | — | US | disclosed |
| US-6822119-B1 | REACTING 3,4-DIHYDRO-6-METHYL-4-PHENYL-2H-BENZOPYRAN-2-ONE WITH DIMETHYL SULFATE USING PHASE TRANSFER CATALYST; DESTERIFICATION, REDUCTION, AMINATION, SULFONATION, DEPROTECTING, DECYCLIZATION, AND SALT FORMATION | RANBAXY LABORATORIES LIMITED (IN) | 2004-11-23 | — | — | US | disclosed |
| EP-1419135-A1 | PROCESS FOR THE PREPARATION OF TOLTERODINE | RANBAXY LABORATORIES, LTD. (IN) | 2004-05-19 | — | — | EP | disclosed |
| WO-2003014060-A1 | PROCESS FOR THE PREPARATION OF TOLTERODINE | RANBAXY LABORATORIES LIMITED (IN) | 2003-02-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140039216-A1 | PROCESS FOR PREPARING FESOTERODINE | FES, QDPR, CYP4F3 | MAPT 1650/4885LMNA 4676/4885CHRM2 417/4885 |
| US-20060094904-A1 | Reacting methyl 3-(2-benzyloxy-5-methyl phenyl)-3-phenylpropionate with a reducing agent to form 3-(2-benzyloxy-5-methylphenyl)-3-phenylpropanol | ADRB3, UGT1A3, COMT | MAPT 400/4885LMNA 2719/4885CHRM2 292/4885 |
| US-20040249211-A1 | PROCESS FOR THE PREPARATION OF TOLTERODINE | ADRB3, ADRA1B, ADRA2B | MAPT 1099/4885LMNA 4055/4885CHRM2 162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.